A comprehensive evaluation of the therapeutic potential of silibinin: a ray of hope in cancer treatment

A comprehensive evaluation of the therapeutic potential of silibinin: a ray of hope in cancer treatment

Natural compounds hold promise in the search for cancer therapies due to their unique chemical structures and combinations that may effectively combat cancer while minimizing toxicity and side effects compared to conventional treatments. Silibinin, a natural lignan, has been found to possess strong...

Full description

Bibliographic Details
Main Authors:	Pantha Prodip Ray, Mohammad Ashraful Islam, Mohammad Safiqul Islam, Aixia Han, Peiwu Geng, Md. Abdul Aziz, Abdullah Al Mamun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Pharmacology
Subjects:	silibinin cancer apoptosis antioxidant anti-inflammatory anti-proliferative
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1349745/full

Similar Items

Design, Synthesis and Biological Evaluation of Glycosylated Derivatives of Silibinin as Potential Anti-Tumor Agents
by: Xi JJ, et al.
Published: (2023-07-01)

Enhanced Anti-Inflammatory Effects of Silibinin and Capsaicin Combination in Lipopolysaccharide-Induced RAW264.7 Cells by Inhibiting NF-κB and MAPK Activation
by: Yingying Zheng, et al.
Published: (2022-06-01)

Silibinin effects on cognitive disorders: Hope or treatment?
by: Zahra Akhoond-Ali, et al.
Published: (2023-11-01)

An Overview on the Effects of Silibinin on Different MicroRNAs Expression in Cancer
by: Vahid Akbari Kordkheyli, et al.
Published: (2018-10-01)

Silibinin, a potential fasting mimetic, inhibits hepatocellular carcinoma by triggering extrinsic apoptosis
by: Biying Xiao, et al.
Published: (2024-01-01)

Doxorubicin and folic acid-loaded zinc oxide nanoparticles-based combined anti-tumor and anti-inflammatory approach for enhanced anti-cancer therapy
by: Soha Gomaa, et al.
Published: (2024-01-01)

Inhibition of Phagocytosis by Silibinin in Mouse Macrophages
by: Kyung-Hoon Sun, et al.
Published: (2023-10-01)

Effect of silibinin on the hyperlipidemia in rats fed with high cholesterol diet
by: Abdullah Arpacı, et al.
Published: (2021-03-01)

Silibinin reduces cell proliferation and migration via EMT pathway in TFK-1 cell line
by: Özel Yetkin Merve, et al.
Published: (2023-12-01)

Protective Effect of Silibinin on Lipopolysaccharide-Induced Inflammatory Responses in Equine Peripheral Blood Mononuclear Cells, an In Vitro Study
by: Enrico Gugliandolo, et al.
Published: (2020-11-01)

Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway
by: Xiaoying Hou, et al.
Published: (2018-02-01)

Silibinin reduces in vitro methane production by regulating the rumen microbiome and metabolites
by: Rui Liu, et al.
Published: (2023-08-01)

A Comprehensive Review of the Cardiovascular Protective Properties of Silibinin/Silymarin: A New Kid on the Block
by: Nikolaos P. E. Kadoglou, et al.
Published: (2022-04-01)

Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells
by: Ha Ra Gu, et al.
Published: (2015-03-01)

Silibinin Schiff Base Derivatives Counteract CCl4-Induced Acute Liver Injury by Enhancing Anti-Inflammatory and Antiapoptotic Bioactivities
by: Xu R, et al.
Published: (2022-05-01)

Biological activities of meroterpenoids isolated from different sources
by: Neeraj Kumar Fuloria, et al.
Published: (2022-09-01)

Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors
by: Sara Verdura, et al.
Published: (2022-12-01)

Neurotrophic Effects of Silibinin on Differentiation of Hair Follicle Stem Cells to Neurons
by: Asalgoo S. (MSc)1; (PhD)2; (PhD)3; (PhD)3; (MSc)4;, et al.
Published: (2010-01-01)

Effects of Silibinin on Nitric Oxide Synthase Genes Expression during Hepatic Warm Ischemia-reperfusion in Adult Male Rats
by: Ehsan nabipour, et al.
Published: (2018-09-01)

In Vitro and In Silico Toxicological Properties of Natural Antioxidant Therapeutic Agent <i>Azima</i> <i>tetracantha</i>. LAM
by: Palanisamy Prakash, et al.
Published: (2021-08-01)

Silibinin Inhibits Cell Ferroptosis and Ferroptosis-Related Tissue Injuries
by: Wentao Duan, et al.
Published: (2023-12-01)

Monocytes from preeclamptic women previously treated with silibinin attenuate oxidative stress in human endothelial cells
by: Virgínia Juliani Gomes, et al.
Published: (2021-04-01)

Phenolic Compounds in Whole Grain Sorghum and Their Health Benefits
by: Jingwen Xu, et al.
Published: (2021-08-01)

A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity
by: Mandeep Singh, et al.
Published: (2023-05-01)

Silibinin upregulates E-cadherin expression in MKN-45 human gastric cancer cells
by: Ebrahim Faghihloo*, et al.
Published: (2018-06-01)

Bio-Actives from Natural Products with Potential Cardioprotective Properties: Isolation, Identification, and Pharmacological Actions of Apigenin, Quercetin, and Silibinin
by: Ekaterina-Michaela Tomou, et al.
Published: (2023-03-01)

JNK and p38 gene and protein expression during liver ischemia-reperfusion in a rat model treated with silibinin
by: Nastaran Aamani, et al.
Published: (2022-11-01)

Investigation of effects of ellagic acid and silibinin on some haematological parameters in rats exposed to ultraviolet radiation
by: Halil Özkol, et al.
Published: (2020-09-01)

An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma
by: Emily K. Colvin, et al.
Published: (2022-08-01)

Design and Synthesis of (2-<i>oxo</i>-1,2-Dihydroquinolin-4-yl)-1,2,3-triazole Derivatives via Click Reaction: Potential Apoptotic Antiproliferative Agents
by: Essmat M. El-Sheref, et al.
Published: (2021-11-01)

Silibinin alleviates intestinal inflammation via inhibiting JNK signaling in Drosophila
by: La Yan, et al.
Published: (2023-09-01)

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice
by: Siarkos Ilias, et al.
Published: (2011-07-01)

Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy
by: Sevda Jafari, et al.
Published: (2023-01-01)

Effect of silibinin and trans-chalcone in an Alzheimer's disease-like model generated by insulin amyloids
by: M. Omidi-Shahsavandi, et al.
Published: (2023-02-01)

The effects of Silibinin on nitrosative stress and matrix metalloproteinase -9 expression in Balb/c mice with breast cancer tumor
by: Farhad Soleimani, et al.
Published: (2020-12-01)

ERα down-regulation plays a key role in silibinin-induced autophagy and apoptosis in human breast cancer MCF-7 cells
by: Nan Zheng, et al.
Published: (2015-07-01)

PEG-Modified <i>tert</i>-Octylcalix[8]arenes as Drug Delivery Nanocarriers of Silibinin
by: Desislava Budurova, et al.
Published: (2021-11-01)

Pharmacological screening of silibinin for antischizophrenic activity along with its acute toxicity evaluation in experimental animals
by: Qurat Ul Ain, et al.
Published: (2023-02-01)

Use of gold nanoparticle-silibinin conjugates: A novel approach against lung cancer cells
by: Rangnath Ravi, et al.
Published: (2022-10-01)

Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells
by: Sara Verdura, et al.
Published: (2022-09-01)